PLUS, psychedelics on capitol hill, Lykos Therapeutics, and Right to Try.
As Congress weighs new psychedelic bills, veterans remain caught between promise, policy, and unresolved ethical concerns.
Legacy media outlets are regularly dropping the ball in this area, fueling confusion about psychedelic policy and its real legal stakes.
As psychedelic access expands, ethical gaps are becoming impossible to ignore.
PLUS psilocybin for weight loss, reishi leather, and empathy for robots
Experts warn DEA’s plan could halt breakthroughs in psychedelic science and threaten public health.
Without ethical guidelines, psychedelic spaces risk harm. Rick Doblin and Jules Evans explore whether a code of conduct could change that.
RFK Jr. and Elon Musk allies are rallying behind reform, but not everyone is onboard
Despite challenges in 2024, the psychedelic movement continues to gain momentum across the United States. Here's a look at what lies ahead in the near term and into 2025.
